Research peptide
KLOW
KLOW consolidates four well-studied repair peptides — BPC-157, TB-500, KPV and GHK-Cu — into one lyophilised vial. Because each constituent engages a distinct but complementary pathway, the blend lets researchers probe multi-pathway tissue-protection, repair and remodelling within a single experimental model. Supplied as an 80mg combined formulation, ≥99% purity by HPLC, Certificate of Analysis on request. UK-based dispatch for preclinical research only. Research applications Multi-pathway tissue-repair and wound-healing modulation studies Anti-inflammatory signalling research via KPV and BPC-157 mechanisms Musculoskeletal regeneration through TB-500 actin-binding pathways Copper-peptide matrix remodelling and collagen-synthesis research Comparisons of combined- versus single-compound repair pathways Specifications Form: Lyophilised powder Purity: ≥99% (HPLC verified) Storage: −20°C, protected from light and moisture Available sizes: 80mg Certificate of Analysis: available on request
Size: 80mg
Multi-buy discount available
- Buy 2Save 5%
- Buy 3Save 10%
- Buy 5Save 15%
- Buy 10Save 20%
- 99%+ purity guaranteed
- COA available
- Same-day dispatch
- Secure checkout
Product details
- KLOW receptor binding and agonism assays in controlled laboratory settings.
- In vitro pathway signalling studies requiring batch-documented research material.
- Analytical method development and HPLC reference characterisation.
- Institutional protocol workstreams that require published Certificates of Analysis.
